SHIRE PLC
Director/PDMR Shareholding
February 17, 2017 - Shire plc (LSE: SHP, NASDAQ: SHPG) (the "Company")
Notification of transactions by person discharging managerial responsibilities
1. Details of the person discharging managerial responsibilities
("PDMR") / person closely associated with them ("PCA")
a) Name Kim Stratton
2. Reason for the notification
a) Position / status Head of International Commercial - PDMR
b) Initial Amendment to prior notification to include the
notification / automatic disposal of Ordinary Shares, as omitted
amendment from the initial notification due to a
transcription error, related to the automatic
exercise of an option as detailed in the initial
notification.
3. Details of the issuer, emission allowance participant, auction
platform, auctioneer or auction monitor
a) Name Shire plc
b) LEI 54930005LQRLI2UXRQ59
4. Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
a) Description of Shire plc Ordinary Shares of 5 pence each
the financial ("Ordinary Shares")
instrument, type
of instrument
Identification ISIN: JE00B2QKY057
code
b) Nature of the Automatic exercise of option over notional
transaction Ordinary Shares granted under the Shire Global
Employee Stock Purchase Plan on November 1, 2015,
and consequent receipt of Ordinary Shares.
c) Price(s) and Price(s) Volume(s)
volume(s)
£40.70 244
d) Aggregated N/A (single transaction)
information
e) Date of the October 31, 2016
transaction
f) Place of the N/A
transaction
5. Details of the transaction(s): section to be repeated for (i) each
type of instrument; (ii) each type of transaction; (iii) each date;
and (iv) each place where transactions have been conducted
a) Description of Shire plc Ordinary Shares of 5 pence each
the financial ("Ordinary Shares")
instrument, type
of instrument
Identification ISIN: JE00B2QKY057
code
b) Nature of the Automatic disposal of Ordinary Shares related to
transaction the automatic option exercise referenced in
section 4. above. The proceeds of this disposal
were used to satisfy personal tax liabilities
arising from the option exercise.
c) Price(s) and Price(s) Volume(s)
volume(s)
£46.07 9
d) Aggregated N/A (single transaction)
information
e) Date of the October 31, 2016
transaction
f) Place of the London Stock Exchange (XLON)
transaction
Oliver Strawbridge
Senior Assistant Company Secretary
For further information please contact:
Investor Relations
Ian Karp ikarp@shire.com +1 781 482 9018
Robert Coates rcoates@shire.com +44 1256 894874
Media
Lisa Adler lisa.adler@shire.com +1 617 588 8607
Debbi Ford debbi.ford@shire.com +1 617 949 9083
NOTES TO EDITORS
About Shire
Shire is the leading global biotechnology company focused on serving people
with rare diseases. We strive to develop best-in-class products, many of which
are available in more than 100 countries, across core therapeutic areas
including Hematology, Immunology, Neuroscience, Ophthalmics, Lysosomal Storage
Disorders, Gastrointestinal / Internal Medicine / Endocrine and Hereditary
Angioedema; and a growing franchise in Oncology.
Our employees come to work every day with a shared mission: to develop and
deliver breakthrough therapies for the hundreds of millions of people in the
world affected by rare diseases and other high-need conditions, and who lack
effective therapies to live their lives to the fullest.
www.shire.com
SHIRE PLC : - Director/PDMR Shareholding
February 17, 2017 at 07:01 am EST
Share
Share
© PRNewswire - 2017
